The involvement of lncRNAs in the development and progression of pancreatic cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA CANCER J CLIN. 2017;67(1):7–30. doi:10.3322/caac.21387.
   PubMed Web of Science ®Google Scholar
• Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447(7146):799–816. doi:10.1038/nature05874.
   PubMed Web of Science ®Google Scholar
• Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101–108. doi:10.1038/nature11233.
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs. insights into functions. Nat Rev Genet. 2009;10(3):155–159. doi:10.1038/nrg2521.
   PubMed Web of Science ®Google Scholar
• Engstrom PG, Suzuki H, Ninomiya N, Akalin A, Sessa L, Lavorgna G, Brozzi A, Luzi L, Tan SL, Yang L et al. Complex Loci in human and mouse genomes. PLoS Genet. 2006;2(4):e47. doi:10.1371/journal.pgen.0020047.
   PubMed Web of Science ®Google Scholar
• Mercer TR, Wilhelm D, Dinger ME, Solda G, Korbie DJ, Glazov EA, Truong V, Schwenke M, Simons C, Matthaei KI et al. Expression of distinct RNAs from 3′ untranslated regions. Nucleic Acids Res. 2011;39(6):2393–2403. doi:10.1093/nar/gkq1158.
   PubMed Web of Science ®Google Scholar
• Preker P, Nielsen J, Kammler S, Lykke-Andersen S, Christensen MS, Mapendano CK, Schierup MH, Jensen TH. RNA exosome depletion reveals transcription upstream of active human promoters. Science (New York, NY). 2008;322(5909):1851–1854. doi:10.1126/science.1164096.
   Google Scholar
• Hirano T, Yoshikawa R, Harada H, Harada Y, Ishida A, Yamazaki T. Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression. Mol Cancer. 2015;14:90. doi:10.1186/s12943-015-0364-7.
   PubMed Web of Science ®Google Scholar
• Yin YF, Yan PX, Lu JL, Song G, Zhu YY, Li ZH, Zhao Y, Shen B, Huang XX, Zhu H et al. Opposing Roles for the lncRNA Haunt and Its Genomic Locus in Regulating HOXA Gene Activation during Embryonic Stem Cell Differentiation. Cell Stem Cell. 2015;16(5):504–516. doi:10.1016/j.stem.2015.03.007.
   PubMed Web of Science ®Google Scholar
• Kong R, Zhang EB, Yin DD, You LH, Xu TP, Chen WM, Xia R, Wan L, Sun M, Wang ZX et al. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer. 2015;14:82. doi:10.1186/s12943-015-0355-8.
   PubMed Web of Science ®Google Scholar
• Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38. doi:10.1186/1476-4598-10-38.
   PubMed Web of Science ®Google Scholar
• Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer discovery. 2011;1(5):391–407. doi:10.1158/2159-8290.CD-11-0209.
   PubMed Web of Science ®Google Scholar
• Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol: an official journal of the United States and Canadian Academy of Pathology, Inc. 2013;26(2):155–165. doi:10.1038/modpathol.2012.160.
   PubMed Web of Science ®Google Scholar
• Li J, Chen Z, Tian L, Zhou C, He MY, Gao Y, Wang S, Zhou F, Shi S, Feng X et al. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Gut. 2014;63(11):1700–1710. doi:10.1136/gutjnl-2013-305806.
   PubMed Web of Science ®Google Scholar
• Zeng S, Xiao YF, Tang B, Hu CJ, Xie R, Yang SM, Li BS. Long Noncoding RNA in Digestive Tract Cancers: Function, Mechanism, and Potential Biomarker. Oncologist. 2015;20(8):898–906. doi:10.1634/theoncologist.2014-0475.
   PubMed Web of Science ®Google Scholar
• Peng W, Gao W, Feng JF. Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer. Medical Oncology. 2014;31(12). doi:10.1007/s12032-014-0346-4.
   Web of Science ®Google Scholar
• Lu XX, Fang Y, Wang ZT, Xie JJ, Zhan Q, Deng XX, Chen H, Jin JB, Peng CH, Li HW et al. Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6. Cell Tissue Res. 2013;354(3):891–896. doi:10.1007/s00441-013-1711-x.
   PubMed Web of Science ®Google Scholar
• Fu XL, Liu DJ, Yan TT, Yang JY, Yang MW, Li J, Huo YM, Liu W, Zhang JF, Hong J et al. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma. Scientific Reports. 2016;6:15. doi:10.1038/srep33535.
   Web of Science ®Google Scholar
• Yu J, Li A, Hong SM, Hruban RH, Goggins M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res: an official journal of the American Association for Cancer Research. 2012;18(4):981–992. doi:10.1158/1078-0432.CCR-11-2347.
   PubMed Web of Science ®Google Scholar
• Xing CY, Hu XQ, Xie FY, Yu ZJ, Li HY, Bin Z, Wu JB, Tang LY, Gao SM: Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia. Febs Letters. 2015;589(15):1981–1987. doi:10.1016/j.febslet.2015.04.061.
   PubMed Web of Science ®Google Scholar
• Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y, Chen W, Liu F, Sun W, Li XF et al. Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA. Cancer Cell. 2016;29(5):653–668. doi:10.1016/j.ccell.2016.03.004.
   PubMed Web of Science ®Google Scholar
• Wang F, Ying HQ, He BS, Pan YQ, Deng QW, Sun HL, Chen J, Liu X, Wang SK. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget. 2015;6(10):7899–7917. doi:10.18632/oncotarget.3219.
   PubMed Web of Science ®Google Scholar
• Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nature genetics. 2010;42(12):1113–1117. doi:10.1038/ng.710.
   PubMed Web of Science ®Google Scholar
• Gao S, Wang P, Hua YQ, Xi H, Meng ZQ, Liu T, Chen Z, Liu LM. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Oncotarget. 2016;7(2):1608–1618. doi:10.18632/oncotarget.6450.
   PubMed Web of Science ®Google Scholar
• Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. BioEssays: news and reviews in molecular, cellular and developmental biology. 2010, 32(6):473–480. doi:10.1002/bies.200900170.
   PubMed Web of Science ®Google Scholar
• Byun HM, Wong HL, Birnstein EA, Wolff EM, Liang G, Yang AS. Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer Res. 2007;67(22):10753–10758. doi:10.1158/0008-5472.CAN-07-0329.
   PubMed Web of Science ®Google Scholar
• Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, Dugimont T, Curgy JJ: Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis. 2002;23(11):1885–1895. doi:10.1093/carcin/23.11.1885.
   PubMed Web of Science ®Google Scholar
• Ma CC, Nong KT, Zhu HD, Wang WW, Huang XY, Yuan Z, Ai KX. H19 promotes pancreatic cancer metastasis by derepressing let-7′s suppression on its target HMGA2-mediated EMT. Tumor Biology. 2014;35(9):9163–9169. doi:10.1007/s13277-014-2185-5.
   PubMedGoogle Scholar
• Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A, Lawrence JB. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Molecular cell. 2009;33(6):717–726. doi:10.1016/j.molcel.2009.01.026.
   PubMed Web of Science ®Google Scholar
• Chakravarty D, Sboner A, Nair SS, Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K, Kossai M et al. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun. 2014;5:5383. doi:10.1038/ncomms6383.
   PubMed Web of Science ®Google Scholar
• Huang B, Liu C, Wu Q, Zhang J, Min QH, Sheng TL, Wang XZ, Zou YQ. Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p. Biochem Biophys Res Commun. 2017;482(4):828–834. doi:10.1016/j.bbrc.2016.11.120.
   PubMed Web of Science ®Google Scholar
• Deng Q, Xie L, Li H. MiR-506 suppresses cell proliferation and tumor growth by targeting Rho-associated protein kinase 1 in hepatocellular carcinoma. Biochem Biophys Res Commun. 2015;467(4):921–927. doi:10.1016/j.bbrc.2015.10.043.
   PubMed Web of Science ®Google Scholar
• Yang H, Liu P, Zhang J, Peng X, Lu Z, Yu S, Meng Y, Tong WM, Chen J. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b. Oncogene. 2016;35(28):3647–3657. doi:10.1038/onc.2015.430.
   PubMed Web of Science ®Google Scholar
• Gastaldi C, Bertero T, Xu N, Bourget-Ponzio I, Lebrigand K, Fourre S, Popa A, Cardot-Leccia N, Meneguzzi G, Sonkoly E et al. miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma. Carcinogenesis. 2014;35(5):1110–1120. doi:10.1093/carcin/bgt490.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang X, Lentz C, Abi-Daoud M, Pare GC, Yang X, Feilotter HE, Tron VA. miR-193b Regulates Mcl-1 in Melanoma. Am J Pathol. 2011, 179(5):2162–2168. doi:10.1016/j.ajpath.2011.07.010.
   PubMed Web of Science ®Google Scholar
• Kranenburg O. The KRAS oncogene: past, present, and future. Biochim Bio Acta. 2005;1756(2):81–82.
   PubMed Web of Science ®Google Scholar
• Zorde Khvalevsky E, Gabai R, Rachmut IH, Horwitz E, Brunschwig Z, Orbach A, Shemi A, Golan T, Domb AJ, Yavin E et al. Mutant KRAS is a druggable target for pancreatic cancer. Proc Natl Acad Sci U S A. 2013;110(51):20723–20728. doi:10.1073/pnas.1314307110.
   PubMed Web of Science ®Google Scholar
• Li X, Deng SJ, Zhu S, Jin Y, Cui SP, Chen JY, Xiang C, Li QY, He C, Zhao SF et al. Hypoxia-induced lncRNA-NUTF2P3–001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway. Oncotarget. 2016;7(5):6000–6014. doi:10.18632/oncotarget.6830.
   PubMed Web of Science ®Google Scholar
• Cai H, Yao J, An Y, Chen X, Chen W, Wu D, Luo B, Yang Y, Jiang Y, Sun D et al. LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer. Oncotarget. 2017.
   Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420–1428. doi:10.1172/JCI39104.
   PubMed Web of Science ®Google Scholar
• Grunert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol. 2003;4(8):657–665. doi:10.1038/nrm1175.
   PubMed Web of Science ®Google Scholar
• Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005;17(5):548–558. doi:10.1016/j.ceb.2005.08.001.
   PubMed Web of Science ®Google Scholar
• Pan Y, Chen J, Tao L, Zhang K, Wang R, Chu X, Chen L. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway. Oncotarget. 2017;8(20):33144–33158.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang J, Shen B, Yin K, Xu J, Gao W, Zhang L. Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition. J Exp Clin Cancer Res: CR. 2015;34:116. doi:10.1186/s13046-015-0229-3.
   PubMed Web of Science ®Google Scholar
• Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta RA et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011;472(7341):120–124. doi:10.1038/nature09819.
   PubMed Web of Science ®Google Scholar
• Li ZH, Zhao XH, Zhou Y, Liu YM, Zhou QB, Ye HL, Wang YX, Zeng JL, Song YD, Gao WC et al. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. J of Transl Med. 2015;13:16. doi:10.1186/s12967-015-0442-z.
   Web of Science ®Google Scholar
• Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031–8041. doi:10.1038/sj.onc.1206928.
   PubMed Web of Science ®Google Scholar
• Jiao F, Hu H, Yuan CC, Wang L, Jiang WH, Jin ZL, Guo Z, Wang LW. Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer. Oncology Reports. 2014;32(6):2485–2492. doi:10.3892/or.2014.3518.
   PubMed Web of Science ®Google Scholar
• Han T, Jiao F, Hu H, Yuan C, Wang L, Jin ZL, Song WF, Wang LW. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer. Oncotarget. 2016;7(10):11194–11207. doi:10.18632/oncotarget.7156.
   PubMed Web of Science ®Google Scholar
• Wang C, Liu X, Chen Z, Huang H, Jin Y, Kolokythas A, Wang A, Dai Y, Wong DT, Zhou X. Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma. Mol Carcinog. 2013;52(3):229–236. doi:10.1002/mc.21848.
   PubMed Web of Science ®Google Scholar
• Zheng S, Chen H, Wang Y, Gao W, Fu Z, Zhou Q, Jiang Y, Lin Q, Tan L, Ye H et al. Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner. Cancer letters. 2016;371(2):354–365. doi:10.1016/j.canlet.2015.12.010.
   PubMed Web of Science ®Google Scholar
• Zhan HX, Wang Y, Li C, Xu JW, Zhou B, Zhu JK, Han HF, Wang L, Wang YS, Hu SY. LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway. Cancer letters. 2016;374(2):261–271. doi:10.1016/j.canlet.2016.02.018.
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105–111. doi:10.1038/35102167.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L, Wu M, Xiong J, Guo X, Liu H. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell. 2013;25(1):69–80. doi:10.1016/j.devcel.2013.03.002.
   PubMed Web of Science ®Google Scholar
• Zhou X, Gao Q, Wang J, Zhang X, Liu K, Duan Z. Linc-RNA-RoR acts as a “sponge” against mediation of the differentiation of endometrial cancer stem cells by microRNA-145. Gynecol Oncol. 2014;133(2):333–339. doi:10.1016/j.ygyno.2014.02.033.
   PubMed Web of Science ®Google Scholar
• Peng F, Li TT, Wang KL, Xiao GQ, Wang JH, Zhao HD, Kang ZJ, Fan WJ, Zhu LL, Li M et al. H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance. Cell Death Dis. 2017;8(1):e2569. doi:10.1038/cddis.2016.438.
   PubMedGoogle Scholar
• Di Cecilia S, Zhang F, Sancho A, Li S, Aguilo F, Sun Y, Rengasamy M, Zhang W, Del Vecchio L, Salvatore F et al. RBM5-AS1 Is Critical for Self-Renewal of Colon Cancer Stem-like Cells. Cancer research. 2016;76(19):5615–5627. doi:10.1158/0008-5472.CAN-15-1824.
   PubMed Web of Science ®Google Scholar
• Lee CJ, Dosch J, Simeone DM. Pancreatic cancer stem cells. J Clin Oncol: official journal of the American Society of Clinical Oncology. 2008;26(17):2806–2812. doi:10.1200/JCO.2008.16.6702.
   PubMed Web of Science ®Google Scholar
• Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PLoS One. 2011;6(6):e20636. doi:10.1371/journal.pone.0020636.
   PubMed Web of Science ®Google Scholar
• Maeda S, Shinchi H, Kurahara H, Mataki Y, Maemura K, Sato M, Natsugoe S, Aikou T, Takao S. CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer. 2008, 98(8):1389–1397. doi:10.1038/sj.bjc.6604307.
   PubMed Web of Science ®Google Scholar
• Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67(3):1030–1037. doi:10.1158/0008-5472.CAN-06-2030.
   PubMed Web of Science ®Google Scholar
• Jiao F, Hu H, Han T, Yuan CC, Wang L, Jin ZL, Guo Z, Wang LW. Long Noncoding RNA MALAT-1 Enhances Stem Cell-Like Phenotypes in Pancreatic Cancer Cells. Int J Mol Sci. 2015;16(4):6677–6693. doi:10.3390/ijms16046677.
   PubMed Web of Science ®Google Scholar
• Bristow RG, Hill RP. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer. 2008;8(3):180–192.
   PubMed Web of Science ®Google Scholar
• Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM, Bastidas AJ, Vierra M. Pancreatic tumors show high levels of hypoxia. Int J Radi Oncol, Biol, Phy. 2000;48(4):919–922. doi:10.1016/S0360-3016(00)00803-8.
   PubMed Web of Science ®Google Scholar
• LaGory EL, Giaccia AJ. The ever-expanding role of HIF in tumour and stromal biology. Nat Cell Biol. 2016;18(4):356–365. doi:10.1038/ncb3330.
   PubMed Web of Science ®Google Scholar
• Erickson LA, Highsmith WE, Jr., Fei P, Zhang J. Targeting the hypoxia pathway to treat pancreatic cancer. Drug Des, Devel Ther. 2015;9:2029–2031.
   PubMed Web of Science ®Google Scholar
• Zhu G, Wang S, Chen J, Wang Z, Liang X, Wang X, Jiang J, Lang J, Li L. Long noncoding RNA HAS2-AS1 mediates hypoxia-induced invasiveness of oral squamous cell carcinoma. Mol Carcinog. 2017;56(10):2210–2222. doi:10.1002/mc.22674.
   Web of Science ®Google Scholar
• Sun YW, Chen YF, Li J, Huo YM, Liu DJ, Hua R, Zhang JF, Liu W, Yang JY, Fu XL et al. A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1 alpha in pancreatic ductal adenocarcinoma. Br J Cancer. 2014;111(11):2131–2141. doi:10.1038/bjc.2014.520.
   PubMed Web of Science ®Google Scholar
• Roberts TC, Morris KV, Weinberg MS. Perspectives on the mechanism of transcriptional regulation by long non-coding RNAs. Epigenetics. 2014;9(1):13–20. doi:10.4161/epi.26700.
   PubMed Web of Science ®Google Scholar
• Faghihi MA, Wahlestedt C. Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol. 2009;10(9):637–643. doi:10.1038/nrm2738.
   PubMed Web of Science ®Google Scholar
• Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van Oudenaarden A et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Nat Acad Sci U S A. 2009;106(28):11667–11672. doi:10.1073/pnas.0904715106.
   PubMed Web of Science ®Google Scholar
• Takayama K, Suzuki T, Tsutsumi S, Fujimura T, Urano T, Takahashi S, Homma Y, Aburatani H, Inoue S. RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer. Oncotarget. 2015;6(4):2263–2276. doi:10.18632/oncotarget.2949.
   PubMed Web of Science ®Google Scholar
• Wang HF, Yang H, Hu LB, Lei YH, Qin Y, Li J, Bi CW, Wang JS, Huo Q. Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells. Genet Mol Res: GMR. 2014;13(4):9939–9950. doi:10.4238/2014.November.27.23.
   PubMed Web of Science ®Google Scholar
• Abbosh PH, Montgomery JS, Starkey JA, Novotny M, Zuhowski EG, Egorin MJ, Moseman AP, Golas A, Brannon KM, Balch C et al. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells. Cancer Res. 2006;66(11):5582–5591. doi:10.1158/0008-5472.CAN-05-3575.
   PubMed Web of Science ®Google Scholar
• Terashima M, Tange S, Ishimura A, Suzuki T. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines. J Biol Chem. 2017;292(1):82–99. doi:10.1074/jbc.M116.750950.
   PubMed Web of Science ®Google Scholar
• Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY. Long noncoding RNA as modular scaffold of histone modification complexes. Science (New York, NY). 2010;329(5992):689–693. doi:10.1126/science.1192002.
   Google Scholar
• Li CH, Xiao ZG, Tong JHM, To KF, Fang XD, Cheng ASL, Chen YC. EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma. Int J Cancer. 2017;140(1):120–129. doi:10.1002/ijc.30414.
   PubMed Web of Science ®Google Scholar
• Cai H, An Y, Chen X, Sun D, Chen T, Peng Y, Zhu F, Jiang Y, He X. Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via up-regulation of insulin-like growth factor 2. Oncotarget. 2016;7(52):86857–86870.
   PubMed Web of Science ®Google Scholar
• Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, Kim S, Safe S. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene. 2013;32(13):1616–1625. doi:10.1038/onc.2012.193.
   PubMed Web of Science ®Google Scholar
• Cheng YT, Jutooru I, Chadalapaka G, Corton JC, Safe S. The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration. Oncotarget. 2015;6(13):10840–10852. doi:10.18632/oncotarget.3450.
   PubMed Web of Science ®Google Scholar
• Feng J, Sun Y, Zhang EB, Lu XY, Jin SD, Guo RH. A novel long noncoding RNA IRAIN regulates cell proliferation in non small cell lung cancer. Int J Clin Exp Pathol. 2015;8(10):12268–12275.
   PubMed Web of Science ®Google Scholar
• Lian YF, Wang J, Feng J, Ding J, Ma ZH, Li J, Peng P, De W, Wang KM. Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer. Tumor Biol. 2016;37(11):14929–14937. doi:10.1007/s13277-016-5380-8.
   PubMedGoogle Scholar
• Xu TP, Liu XX, Xia R, Yin L, Kong R, Chen WM, Huang MD, Shu YQ. SP1-induced upregulation of the long noncoding RNA TINCR regulates cell proliferation and apoptosis by affecting KLF2 mRNA stability in gastric cancer. Oncogene. 2015;34(45):5648–5661. doi:10.1038/onc.2015.18.
   PubMed Web of Science ®Google Scholar
• Wolff L, Bies J. p15Ink4b Functions in determining hematopoietic cell fates: implications for its role as a tumor suppressor. Blood Cells, Mol Dis. 2013, 50(4):227–231. doi:10.1016/j.bcmd.2013.01.006.
   PubMed Web of Science ®Google Scholar
• O'Leary VB, Ovsepian SV, Carrascosa LG, Buske FA, Radulovic V, Niyazi M, Moertl S, Trau M, Atkinson MJ, Anastasov N. PARTICLE, a Triplex-Forming Long ncRNA, Regulates Locus-Specific Methylation in Response to Low-Dose Irradiation. Cell Reports. 2015;11(3):474–485. doi:10.1016/j.celrep.2015.03.043.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu N, Liu B, Huang Y, Zeng H, Yang Z, He Z, Guo H. Long noncoding RNA RP11–838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines. Oncotarget. 2016;7(28):43835–43851. doi:10.18632/oncotarget.9699.
   PubMed Web of Science ®Google Scholar
• Izumiya M, Kabashima A, Higuchi H, Igarashi T, Sakai G, Iizuka H, Nakamura S, Adachi M, Hamamoto Y, Funakoshi S et al. Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells. Anticancer Res. 2012;32(9):3847–3853.
   PubMed Web of Science ®Google Scholar
• You L, Chang D, Du HZ, Zhao YP. Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells. Biochem Biophy Res Commun. 2011;407(1):1–6. doi:10.1016/j.bbrc.2011.02.027.
   PubMed Web of Science ®Google Scholar
• Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS, Feng XJ. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol. 2014;7(10):6929–6935.
   PubMed Web of Science ®Google Scholar
• Fang XY, Pan HF, Leng RX, Ye DQ. Long noncoding RNAs: novel insights into gastric cancer. Cancer lett. 2015;356(2 Pt B):357–366. doi:10.1016/j.canlet.2014.11.005.
   PubMed Web of Science ®Google Scholar
• Zhang XW, Bu P, Liu L, Zhang XZ, Li J. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance. Biochem Biophy Res Commun. 2015;462(3):227–232. doi:10.1016/j.bbrc.2015.04.121.
   PubMed Web of Science ®Google Scholar
• Fang H, Declerck YA. Targeting the tumor microenvironment: from understanding pathways to effective clinical trials. Cancer Res. 2013;73(16):4965–4977. doi:10.1158/0008-5472.CAN-13-0661.
   PubMed Web of Science ®Google Scholar
• Orimo A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle. 2006;5(15):1597–1601. doi:10.4161/cc.5.15.3112.
   PubMed Web of Science ®Google Scholar
• Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature. 2001;411(6835):375–379. doi:10.1038/35077241.
   PubMed Web of Science ®Google Scholar
• Kuniyasu H, Abbruzzese JL, Cleary KR, Fidler IJ. Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. Int J Oncol. 2001;19(4):681–685.
   PubMed Web of Science ®Google Scholar
• Hartel M, Di Mola FF, Gardini A, Zimmermann A, Di Sebastiano P, Guweidhi A, Innocenti P, Giese T, Giese N, Buchler MW et al. Desmoplastic reaction influences pancreatic cancer growth behavior. World J Surg. 2004;28(8):818–825. doi:10.1007/s00268-004-7147-4.
   PubMed Web of Science ®Google Scholar
• Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392–401. doi:10.1038/nrc1877.
   PubMed Web of Science ®Google Scholar
• McAllister SS, Weinberg RA. Tumor-host interactions: a far-reaching relationship. J Clin Oncol: official journal of the American Society of Clinical Oncology. 2010;28(26):4022–4028. doi:10.1200/JCO.2010.28.4257.
   PubMed Web of Science ®Google Scholar
• Zhuang J, Lu Q, Shen B, Huang X, Shen L, Zheng X, Huang R, Yan J, Guo H. TGFbeta1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT. Sci Rep. 2015;5:11924. doi:10.1038/srep11924.
   PubMed Web of Science ®Google Scholar
• Nelles L, Van de Putte T, van Grunsven L, Huylebroeck D, Verschueren K. Organization of the mouse Zfhx1b gene encoding the two-handed zinc finger repressor Smad-interacting protein-1. Genomics. 2003;82(4):460–469. doi:10.1016/S0888-7543(03)00169-1.
   PubMed Web of Science ®Google Scholar
• Zhao L, Ji G, Le X, Wang C, Xu L, Feng M, Zhang Y, Yang H, Xuan Y, Yang Y et al. Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer. Cancer Res. 2017;77(6):1369–1382. doi:10.1158/0008-5472.CAN-16-1615.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011, 144(5):646–674. doi:10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Bailey JM, Swanson BJ, Hamada T, Eggers JP, Singh PK, Caffery T, Ouellette MM, Hollingsworth MA. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res: an official journal of the American Association for Cancer Research. 2008;14(19):5995–6004. doi:10.1158/1078-0432.CCR-08-0291.
   PubMed Web of Science ®Google Scholar
• Lohr M, Schmidt C, Ringel J, Kluth M, Muller P, Nizze H, Jesnowski R. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res. 2001;61(2):550–555.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249–257. doi:10.1038/35025220.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature. 2005;438(7070):967–974. doi:10.1038/nature04483.
   PubMed Web of Science ®Google Scholar
• Jia P, Cai H, Liu X, Chen J, Ma J, Wang P, Liu Y, Zheng J, Xue Y. Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells by inhibiting microRNA-29a. Cancer lett. 2016;381(2):359–369. doi:10.1016/j.canlet.2016.08.009.
   PubMed Web of Science ®Google Scholar
• Conigliaro A, Costa V, Lo Dico A, Saieva L, Buccheri S, Dieli F, Manno M, Raccosta S, Mancone C, Tripodi M et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol Cancer. 2015;14:155. doi:10.1186/s12943-015-0426-x.
   PubMed Web of Science ®Google Scholar
• Kondo A, Nonaka A, Shimamura T, Yamamoto S, Yoshida T, Kodama T, Aburatani H, Osawa T. Long Noncoding RNA JHDM1D-AS1 Promotes Tumor Growth by Regulating Angiogenesis in Response to Nutrient Starvation. Mol Cell Biol. 2017;37(18). doi:10.1128/MCB.00125-17.
   Web of Science ®Google Scholar
• de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6(1):24–37. doi:10.1038/nrc1782.
   PubMed Web of Science ®Google Scholar
• Ruffell B, DeNardo DG, Affara NI, Coussens LM. Lymphocytes in cancer development: polarization towards pro-tumor immunity. Cytokine Growth Factor Rev. 2010;21(1):3–10. doi:10.1016/j.cytogfr.2009.11.002.
   PubMed Web of Science ®Google Scholar
• Noh KH, Kim BW, Song KH, Cho H, Lee YH, Kim JH, Chung JY, Kim JH, Hewitt SM, Seong SY et al. Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest. 2012;122(11):4077–4093. doi:10.1172/JCI64057.
   PubMed Web of Science ®Google Scholar
• Pedoeem A, Azoulay-Alfaguter I, Strazza M, Silverman GJ, Mor A. Programmed death-1 pathway in cancer and autoimmunity. Clin Immunol (Orlando, Fla). 2014;153(1):145–152. doi:10.1016/j.clim.2014.04.010.
   PubMed Web of Science ®Google Scholar
• Muenst S, Soysal SD, Gao F, Obermann EC, Oertli D, Gillanders WE. The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer. Breast Cancer Res Treat. 2013;139(3):667–676. doi:10.1007/s10549-013-2581-3.
   PubMed Web of Science ®Google Scholar
• Thompson RH, Dong H, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Kwon ED. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin Cancer Res: an official journal of the American Association for Cancer Research. 2007;13(6):1757–1761. doi:10.1158/1078-0432.CCR-06-2599.
   PubMed Web of Science ®Google Scholar
• Chapon M, Randriamampita C, Maubec E, Badoual C, Fouquet S, Wang SF, Marinho E, Farhi D, Garcette M, Jacobelli S et al. Progressive upregulation of PD-1 in primary and metastatic melanomas associated with blunted TCR signaling in infiltrating T lymphocytes. J Invest Dermatol. 2011;131(6):1300–1307. doi:10.1038/jid.2011.30.
   PubMed Web of Science ®Google Scholar
• Tang Y, He Y, Shi L, Yang L, Wang J, Lian Y, Fan C, Zhang P, Guo C, Zhang S et al. Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma. Oncotarget. 2017;8(24):39001–39011.
   PubMed Web of Science ®Google Scholar
• Ye Y, Chen J, Zhou Y, Fu Z, Zhou Q, Wang Y, Gao W, Zheng S, Zhao X, Chen T et al. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma. J Transl Med. 2015;13:137. doi:10.1186/s12967-015-0490-4.
   PubMed Web of Science ®Google Scholar
• Lu C, Paschall AV, Shi H, Savage N, Waller JL, Sabbatini ME, Oberlies NH, Pearce C, Liu K. The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion. JNCI-J Natl Cancer Inst. 2017;109(6):12. doi:10.1093/jnci/djw283.
   Web of Science ®Google Scholar